共 50 条
- [11] Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLC CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1323 - 1327
- [20] Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (08):